AVY vs CITR vs SCL Stock Comparison

Avery Dennison, CitroTech and Stepan Prices as of Oct 26, 2026 Peers: Industry group
AVY Avery Dennison Corp
$183.42 +7.7% 1M +1.0% 1Y
Market cap
$13.86B
P/E
19.7x
Revenue (TTM)
$9.25B
Div. yield
0.02%
Specialty Chemicals Basic Materials
7 wins
CITR CitroTech Inc.
$2.69 -38.0% 1M -73.1% 1Y
Market cap
$58.02M
P/E
–
Revenue (TTM)
$1.35M
Div. yield
–
Specialty Chemicals Basic Materials
1 win
SCL Stepan Co
$64.96 +0.9% 1M +40.8% 1Y
Market cap
$1.49B
P/E
–
Revenue (TTM)
$2.43B
Div. yield
–
Specialty Chemicals Basic Materials
2 wins

Head to Head

10 decided of 12

Avery Dennison leads on 7 of the 12 questions below (Avery Dennison 7, Stepan 2, CitroTech 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionAVYCITRSCLLeader
Larger companyMarket capitalisation $13.86B $58.02M $1.49B AVY
Cheaper on earningsLower P/E, profitable companies only 19.7x -1.8x -3,390x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 17.3x — 23.0x AVY
Faster revenue growthRevenue growth, trailing twelve months +5.8% -26.4% +7.6% SCL
More profitableNet margin, trailing twelve months 7.6% -2,373.6% 0.0% AVY
Better return on capitalReturn on invested capital 14.3% — 1.1% AVY
Less leveragedLower net debt / EBITDA 2.3x — 3.6x AVY
Higher dividend yieldTrailing dividend yield 0.02% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +1.0% -73.1% +40.8% SCL
Better 5-year returnAnnualised price return, 5 years -2.5%/yr +37.9%/yr -11.4%/yr CITR
Less volatileAnnualised volatility, 1 year 23.5% 84.2% 37.6% AVY
Higher overall scoreMean of the five percentile scores vs peers 69/100 24/100 48/100 AVY

Percentile Scorecard

AVYCITRSCL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisAVYCITRSCL
Valuation 60 #38 of 94 4 #90 of 94 68 #31 of 94
Growth 84 #16 of 92 4 #88 of 92 41 #55 of 92
Profitability 93 #7 of 89 3 #86 of 89 51 #44 of 89
Financial Health 33 #65 of 97 94 #7 of 97 37 #62 of 97
Shareholder Returns 77 #17 of 70 16 #59 of 70 46 #38 of 70
Overall 69 24 48
  • AVY ranked among 99 companies in Chemicals
  • CITR ranked among 99 companies in Chemicals
  • SCL ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodAVYCITRSCLSPY
1 month +7.7%-38.0%+0.9% -0.8%
3 months +12.5%-54.2%+12.7% +3.5%
6 months +11.2%-58.9%+23.4% +7.0%
Year to date +0.8%-66.7%+37.2% +12.2%
1 year +1.0%-73.1%+40.8% +13.0%
3 years +7.6%-24.9%-12.9% +86.3%
3 years, per year +2.5%-9.1%-4.5% +23.1%
5 years -11.9%+398.1%-45.4% +68.6%
5 years, per year -2.5%+37.9%-11.4% +11.0%
10 years +158.5%+49,714.8%-7.7% +258.0%
10 years, per year +10.0%+86.1%-0.8% +13.6%

Risk

MeasureAVYCITRSCLSPY
Volatility, 1Y 23.5%84.2%37.6% 12.7%
Downside volatility, 1Y 21.7%85.7%41.4% 12.7%
Beta vs S&P 500, 1Y 0.480.610.65 1.00
Return / volatility, 1Y 0.04-0.871.09 1.02
Max drawdown, 5Y -33.3%-79.7%-67.1% -25.4%
From 52-week high -7.1%-73.3%-3.4% -1.8%
52-week high $197.45$10.09$67.23 $779.14
52-week low $153.01$2.55$42.31 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleAVYCITRSCL
P/E now vs peer median 19.9xmedian 21.6x -1.8xmedian 21.6x -3,380xmedian 21.6x
P/S now vs peer median 1.5xmedian 1.4x 44.9xmedian 1.4x 0.6xmedian 1.4x
EV/EBITDA now vs peer median 11.4xmedian 12.4x -3.8xmedian 12.4x 13.5xmedian 12.4x
P/FCF now vs peer median 13.1xmedian 15.8x -7.7xmedian 15.8x 40.4xmedian 15.8x
P/B now vs peer median 6.0xmedian 1.6x 6.7xmedian 1.6x 1.2xmedian 1.6x
PEG now vs peer median 2.05median 1.66 0.01median 1.66 125.74median 1.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsAVYCITRSCL
Revenue $9.25B $1.35M $2.43B
Gross profit $2.68B -$69.56K $287.37M
Operating income $1.19B -$17.96M $19.88M
Net income $704.90M -$24.14M -$2.65M
Free cash flow $1.06B -$7.82M $36.58M
R&D – $327.90K $62.12M
EPS (diluted) $9.23 $-1.47 $-0.02
Cash & equivalents $227.30M $2.52M $113.71M
Total debt $14.80B $3.73M $2.58B
Shares (diluted) 76.40M 21.75M 22.92M
Enterprise value $12.64B $38.75M $985.81M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricAVYCITRSCL
P/E 19.9x -1.8x -3,380x
P/FCF 13.1x -7.7x 40.4x
P/Operating cash flow 11.3x -7.8x 9.5x
P/S 1.5x 44.9x 0.6x
P/B 6.0x 6.7x 1.2x
P/Tangible book 9.0x 15.6x 1.3x
EV/EBITDA 11.4x -3.8x 13.5x
EV/EBIT 14.6x -3.2x 101.1x
EV/Revenue 1.9x 43.0x 0.8x
EV/FCF 16.3x -7.4x 55.0x
EV/Operating cash flow 14.1x -7.5x 13.0x
PEG (3Y EPS CAGR) 2.05 0.01 125.74

Growth

14 metrics
MetricAVYCITRSCL
Revenue growth (1Y) 5.8% -26.4% 7.6%
Revenue CAGR (3Y) 2.9% 134.1% -1.9%
Gross profit growth (1Y) 7.4% -117.9% 2.7%
Gross profit CAGR (3Y) 6.6% -39.1% -4.1%
Operating income growth (1Y) 5.9% -118.1% -74.5%
Operating income CAGR (3Y) 8.9% -134.7% -42.6%
Net income growth (1Y) -0.9% 29.2% -104.6%
Net income CAGR (3Y) 7.6% -162.9% -26.7%
EPS growth (1Y) 1.6% 68.0% -46.9%
EPS CAGR (3Y) 9.7% -171.6% -26.9%
Operating cash flow growth (1Y) 51.6% -151.6% 42.1%
Operating cash flow CAGR (3Y) 17.6% -108.6% -0.7%
Free cash flow growth (1Y) 67.3% -139.8% 401.8%
Free cash flow CAGR (3Y) 31.2% -108.7% 30.3%

Profitability

14 metrics
MetricAVYCITRSCL
Gross margin 29.0% -5.2% 11.8%
EBITDA margin 16.5% -1,128% 6.1%
Operating margin 12.8% -1,330% 0.8%
Pretax margin 10.4% -1,788% 0.0%
Net margin 7.6% -2,374% 0.0%
FCF margin 11.5% -579.5% 1.5%
Operating cash flow margin 13.3% -576.8% 6.4%
Return on equity 30.5% -272.8% -0.2%
Return on assets 7.8% -216.8% -0.1%
Return on invested capital 14.3% – 1.1%
Return on capital employed 19.5% -167.6% 1.3%
Asset turnover 1.0x 0.1x 1.0x
Cash conversion (OCF / net income) 1.8x 0.3x -58.5x
Stock comp / revenue 0.3% 742.9% 0.3%

Financial Health

11 metrics
MetricAVYCITRSCL
Debt / assets 39.9% – 27.1%
Debt / equity 1.6x – 0.5x
Net debt / EBITDA 2.3x – 3.6x
Debt / FCF 3.5x – 17.7x
Liabilities / assets 74.8% 10.2% 49.3%
Equity / assets 25.2% 89.8% 50.7%
Interest coverage 8.4x -10.0x –
Current ratio 1.1x 8.8x 1.2x
Quick ratio 0.7x 6.4x 0.7x
Cash ratio 0.1x 6.0x 0.1x
Altman Z-score 3.58 12.93 2.59

Shareholder Returns

7 metrics
MetricAVYCITRSCL
Dividend yield 2.1% – 2.5%
Net buyback yield 2.9% -0.4% 0.0%
Shareholder yield 5.1% -0.4% 2.4%
Payout ratio (earnings) 41.7% – –
Payout ratio (FCF) 27.7% – –
Dividend growth (1Y) 3.4% – –
Dividend CAGR (3Y) 5.9% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusAVYCITRSCL
Forward P/E 17.3xFY2026 – 23.0xFY2026
EPS, next fiscal year $10.61FY2026 – $2.83FY2026
EPS growth, next FY +11.3%FY2026 – +55.5%FY2026
EPS growth, the year after +7.9% – +23.7%
Revenue, next fiscal year $9.82BFY2026 – $2.38BFY2026
Revenue growth, next FY +10.9%FY2026 – +2.3%FY2026
Revenue growth, the year after +0.1% – +16.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersAVYCITRSCL
Held by institutions 97.4% 9.7% 87.2%
Institutions holding 783 26 231
Change in shares held, QoQ +2.7% +24.3% +1.5%
Institutions buying 384 20 122
Institutions selling 272 1 68
Buyers to sellers 1.41 20.00 1.79

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

AVYCITRSCL
AVY 1.00 0.04 0.34
CITR 0.04 1.00 -0.01
SCL 0.34 -0.01 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, AVY, CITR and SCL?

Avery Dennison (AVY) is the largest by market capitalisation: Avery Dennison (AVY) $13.86B, CitroTech (CITR) $58.02M, Stepan (SCL) $1.49B.

Which company is growing faster?

Stepan (SCL) grew revenue fastest over the trailing twelve months: Avery Dennison (AVY) +5.8%, CitroTech (CITR) -26.4%, Stepan (SCL) +7.6%.

Which company is more profitable?

Avery Dennison (AVY) has the highest net margin (Avery Dennison (AVY) 7.6%, CitroTech (CITR) -2,373.6%, Stepan (SCL) 0.0%). On return on invested capital, Avery Dennison (AVY) leads (Avery Dennison (AVY) 14.3%, Stepan (SCL) 1.1%).

Which stock has performed better?

Over the past year Stepan (SCL) returned the most: Avery Dennison (AVY) +1.0%, CitroTech (CITR) -73.1%, Stepan (SCL) +40.8%. Over five years, CitroTech (CITR) compounded fastest (Avery Dennison (AVY) -2.5%/yr, CitroTech (CITR) +37.9%/yr, Stepan (SCL) -11.4%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Avery Dennison (AVY) 0.02%, CitroTech (CITR) 0.00%, Stepan (SCL) 0.00%. CitroTech (CITR) and Stepan (SCL) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Avery Dennison (AVY) has been the steadiest (Avery Dennison (AVY) 23.5%, CitroTech (CITR) 84.2%, Stepan (SCL) 37.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, AVY, CITR and SCL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Avery Dennison (AVY) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.